Evidence map›Paper›PMID 36670904›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Fundamental Role of Pentose Phosphate Pathway within the Endoplasmic Reticulum in Glutamine Addiction of Triple-Negative Breast Cancer Cells.

Cecilia Marini, Vanessa Cossu, Sonia Carta, Elisa Greotti, Daniela Gaglio, Nadia Bertola, Sabrina Chiesa, Silvia Bruno, Francesca Vitale, Marcella Bonanomi and 7 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. A fingerprint of 2-[iScience · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Cecilia MariniInstitute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), 20054 Milan, Italy.
Vanessa CossuIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Sonia CartaIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.ORCID 0000-0002-1278-9761
Elisa GreottiDepartment of Biomedical Sciences, University of Padova, 35131 Padua, Italy.ORCID 0000-0003-3702-4789
Daniela GaglioInstitute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), 20054 Milan, Italy.
Nadia BertolaDepartment of Experimental Medicine, Human Anatomy, University of Genoa, 16132 Genova, Italy.ORCID 0000-0003-4591-3260
Sabrina ChiesaIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Silvia BrunoDepartment of Experimental Medicine, Human Anatomy, University of Genoa, 16132 Genova, Italy.
Francesca VitaleIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Marcella BonanomiISBE. IT, Centre of Systems Biology, 20126 Milan, Italy.ORCID 0000-0003-0886-7613
Danilo PorroInstitute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), 20054 Milan, Italy.
Mattia RiondatoIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Anna Maria OrengoIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Matteo BaucknehtIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.ORCID 0000-0002-1937-9116
Silvia MorbelliIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Silvia RaveraDepartment of Experimental Medicine, Human Anatomy, University of Genoa, 16132 Genova, Italy.ORCID 0000-0002-0803-1042
Gianmario SambucetiIRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.ORCID 0000-0003-2979-6500
Ospedale Policlinico San Martino · ITInstitute of Molecular Bioimaging and Physiology · ITUniversity of Genoa · ITUniversity of Milano-Bicocca · ITUniversity of Padua · IT

Funding

Italian Association for Cancer Research IG 23201Italian Ministry of Health - 5x1000 2020 5x1000 2020
6 · The paper itself

Abstract

Cancer utilization of large glutamine equivalents contributes to diverging glucose-6-P flux toward the pentose phosphate shunt (PPP) to feed the building blocks and the antioxidant responses of rapidly proliferating cells. In addition to the well-acknowledged cytosolic pathway, cancer cells also run a largely independent PPP, triggered by hexose-6P-dehydrogenase within the endoplasmic reticulum (ER), whose activity is mandatory for the integrity of ER-mitochondria networking. To verify whether this reticular metabolism is dependent on glutamine levels, we complemented the metabolomic characterization of intermediates of the glucose metabolism and tricarboxylic acid cycle with the estimation of proliferating activity, energy metabolism, redox damage, and mitochondrial function in two breast cancer cell lines. ER-PPP activity and its determinants were estimated by the ER accumulation of glucose analogs. Glutamine shortage decreased the proliferation rate despite increased ATP and NADH levels. It depleted NADPH reductive power and increased malondialdehyde content despite a marked increase in glucose-6P-dehydrogenase. This paradox was explained by the deceleration of ER-PPP favored by the decrease in hexose-6P-dehydrogenase expression coupled with the opposite response of its competitor enzyme glucose-6P-phosphatase. The decreased ER-PPP activity eventually hampered mitochondrial function and calcium exchanges. These data configure the ER-PPP as a powerful, unrecognized regulator of cancer cell metabolism and proliferation.

Indexed as

18F-fluoro-deoxy-glucosebreast cancercalcium fluxendoplasmic reticulumendoplasmic reticulum–mitochondria networkglutamine metabolismhexose-6-phosphate-dehydrogenasepentose phosphate pathwayredox balance

Identifiers

PMID36670904
PMCPMC9854646
OpenAlexW4312202421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.